Simon Jose
Corporate Officer/Principal bei IDORSIA LTD
Vermögen: 101 154 $ am 31.03.2024
Profil
Simon Jose is currently the Chief Commercial Officer & Executive VP at Idorsia Ltd.
Prior to this, he worked as the President at The Association of the British Pharmaceutical Industry from 2011 to 2012, as the President at Stiefel Laboratories, Inc. from 2012 to 2014, and as the Vice President & General Manager at GlaxoSmithKline Pharma A.
He also worked as a Principal at GSK Plc and The Danish Association of the Pharmaceutical Industry.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IDORSIA LTD.
0,02% | 31.12.2022 | 32 217 ( 0,02% ) | 101 154 $ | 31.03.2024 |
Aktive Positionen von Simon Jose
Unternehmen | Position | Beginn |
---|---|---|
IDORSIA LTD | Corporate Officer/Principal | 01.12.2018 |
Ehemalige bekannte Positionen von Simon Jose
Unternehmen | Position | Ende |
---|---|---|
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | President | 01.01.2014 |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | President | 01.01.2012 |
The Danish Association of the Pharmaceutical Industry | Corporate Officer/Principal | - |
GlaxoSmithKline Pharma A/S
GlaxoSmithKline Pharma A/S Medical DistributorsDistribution Services GlaxoSmithKline Pharma A/S operates as a science-led global healthcare company. It develops and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company was founded on December 11, 1968 and is headquartered in Brondby, Denmark. | Corporate Officer/Principal | - |
GSK PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
IDORSIA LTD | Health Technology |
Private Unternehmen | 4 |
---|---|
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
GlaxoSmithKline Pharma A/S
GlaxoSmithKline Pharma A/S Medical DistributorsDistribution Services GlaxoSmithKline Pharma A/S operates as a science-led global healthcare company. It develops and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company was founded on December 11, 1968 and is headquartered in Brondby, Denmark. | Distribution Services |
The Danish Association of the Pharmaceutical Industry |